Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Humana ABLTS:0RF7 +0.56%69 5-Year Yield-on-Cost % is 2.14 as of Jul. 20, 2026, which is 62% above its 10-year median of 1.32. GuruFocus rates LTS:0RF7 with a GF Score™ of 69/100 and a GF Value™ of kr36.56 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 279 Healthcare Providers & Services companies, Humana AB ranks worse than 59.86% on this metric.
Humana AB's yield on cost for the quarter that ended in Jun. 2026 was 2.14.
The historical rank and industry rank for Humana AB's 5-Year Yield-on-Cost % or its related term are showing as below:
LTS:0RF7'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.79 Med: 1.32 Max: 2.94
Current: 2.14
During the past 13 years, Humana AB's highest Yield on Cost was 2.94. The lowest was 0.79. And the median was 1.32.
LTS:0RF7's 5-Year Yield-on-Cost % is ranked worse than 59.86% of 279
companies
in the Healthcare Providers & Services industry
Industry Median: 2.93
vs LTS:0RF7: 2.14
Humana AB (LTS:0RF7) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Humana AB 5-Year Yield-on-Cost % Related Terms
LTS:0RF7 vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Humana AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humana AB 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Humana AB's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Humana AB's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Humana AB is calculated as
Humana AB (LTS:0RF7) has a 5-Year Yield-on-Cost % of 2.14 as of Jul. 20, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Humana AB and its competitors. This is 62% above median its historical median of 1.32. Over the past decade, Humana AB's 5-Year Yield-on-Cost % has ranged from 0.79 to 2.94. According to the industry distribution chart, Humana AB ranks #167 out of 279 companies in the Healthcare Providers & Services industry, placing it in the top 59.9%.
Is Humana AB's 5-Year Yield-on-Cost % too high?
Humana AB's current 5-Year Yield-on-Cost % of 2.14 is 62% above median its 10-year median of 1.32. Over the past 10 years, this metric has ranged from a low of 0.79 to a high of 2.94. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.93. Humana AB's value of 2.14 is 27% below this industry median. Based on the distribution chart, Humana AB ranks #167 out of 279 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Humana AB has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Humana AB's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Humana AB ranks #167 out of 279 companies for 5-Year Yield-on-Cost %. This places Humana AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. Humana AB's value of 2.14 is 27% below this benchmark. Historically, Humana AB's own 5-Year Yield-on-Cost % has ranged from 0.79 to 2.94 over the past decade. While the company's 10-year median is 1.32 vs. the industry median of 2.93, Humana AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 279 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humana AB's current 5-Year Yield-on-Cost % of 2.14 is 27% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Humana AB and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humana AB's current 5-Year Yield-on-Cost % is 2.14, which is 62% above median its own 10-year median of 1.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana AB stock overvalued right now?
Based on GuruFocus' analysis, Humana AB (LTS:0RF7) is currently considered Significantly Overvalued. The stock's GF Value™ is kr36.56, compared to a current price of kr63.15 — trading 72.7% above its estimated fair value. The current 5-Year Yield-on-Cost % is 2.14, which is 62% above median its 10-year median of 1.32 and 27% below the Healthcare Providers & Services industry median of 2.93. Humana AB's overall GF Score™ is 69/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Humana AB (LTS:0RF7), the current 5-Year Yield-on-Cost % is 2.14 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humana AB (LTS:0RF7) Overvalued in 2026?
Based on GuruFocus' analysis, Humana AB stock appears to be overvalued.
The current stock price of kr63.15 is trading 72.7% above its estimated GF Value™ of kr36.56.
GuruFocus considers Humana AB to be Significantly Overvalued.
Key valuation signals for LTS:0RF7:
5-Year Yield-on-Cost %: 2.14 (62% above median its 10-year median of 1.32)
GF Value™: kr36.56 vs. price of kr63.15 (72.7% above fair value)
Industry Position: 27% below the Healthcare Providers & Services median (#167 of 279)
No single metric tells the full story. See the LTS:0RF7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humana AB is a provider of private care services in the Nordic region. The company offers services including individual and family care, personal assistance, elderly care and housing with special services. Geographically, the company operates in Sweden, Norway, Finland, Denmark, and others. It derives maximum revenue from Sweden.
69GF Score
Get the complete analysis for LTS:0RF7
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RF7 has been successfully added to your 
